Cost analysis of cannabis on the NHS to launch next month

Cost analysis of cannabis on the NHS to launch next month
Cannabis Health News

A new project, designed to show how cannabis would be cost-effective on the NHS, is due to get underway next month. Experts at York Health Economics Consortium are to develop a flexible health economics analysis tool to evaluate the feasibility of prescribing cannabis on the NHS.  The research will include a financial comparison of cannabis and other treatments for tackling chronic pain, alongside a consideration of cost and outcomes over a one-year time period. The project, which is being supported by the Cannabis Industry Council (CIC) and Drug Science, is due to start next month after securing funding from a range of backers.   The tool will consider the costs, resource use and utility of medicinal cannabis and will assess the viability of prescribing cannabis on the NHS under different scientific assumptions. Chair of the CIC, Professor Mike Barnes, has previously said he believes cannabis could be made available on the NHS at a ‘net-zero’ cost.  Glass Pharms, Ethypharm and Rua Bioscience have provided financial support, while additional funding was secured via an industry crowdfunder, held in late 2022. The project was hoping to raise £18,000-20,000, of which over 50% has been secured, Cannabis Health understands. James Duckenfield, CEO of Glass Pharms, commented: “A recent study published in the US has shown chronic pain patients using medical cannabis were able to reduce their use of other pain medications by more than 50%. If the NHS was to offer this in the UK, we could see benefits both for patients and potential cost savings for healthcare. “We are supporting this health economics analysis to help provide the data needed for the NHS to make an informed decision on this.” Drug Science will also make T21 project data available to the researchers. “Many patients are successfully using cannabis-based medicinal products to treat chronic…

Excerpt only …
READ MORE BELOW
Source : Cost analysis of cannabis on the NHS to launch next month

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.